The KrebsScan cancer screening program combines the PanTum Detect® blood test with the strengths of imaging techniques (PET-CT/MRI).
Study shows with the help of PanTum Detect®: Significantly increased TKTL1 and DNasex (Apo10) levels in children and adolescents with rhabdomyosarcoma.
Tübingen researchers: PanTum Detect® blood test is able to distinguish between children / adolescents with neuroblastoma and healthy individuals.
Study shows: PanTum Detect® test paves the way for the targeted use of imaging methods for early cancer detection. (Press Release in german language)